MJardin Receives Cultivation and Processing License at Second Ontario Facility
TORONTO and DENVER, Feb. 19, 2020 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), […]
TORONTO and DENVER, Feb. 19, 2020 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), […]
CAMBRIDGE, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed […]
MALVERN, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing […]
Full year net income from continuing operations of $55.7 million Backlog of $589.4 million at December 31, 2019OAK BROOK, Ill., Feb. […]
CAMBRIDGE, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine […]
42.8% ORR in multiple myeloma at the 75mCi total body dose42.0% ORR and 11% CRR in all non-Hodgkin’s lymphoma (NHL) […]
CALGARY, Alberta, Feb. 19, 2020 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT”) (TSX: DRT, NASDAQ: DRTT), an interior construction […]
JOHNS CREEK, Ga., Feb. 19, 2020 (GLOBE NEWSWIRE) — Ebix, Inc., (NASDAQ: EBIX) a leading international supplier of On-Demand software […]
Heidelberg, Germany, February 19, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate […]
DUBLIN, Ireland and TREVOSE, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical […]